{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T15:01:15Z","timestamp":1778338875939,"version":"3.51.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,23]],"date-time":"2019-02-23T00:00:00Z","timestamp":1550880000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,2,23]],"date-time":"2019-02-23T00:00:00Z","timestamp":1550880000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004160","name":"Mazandaran University of Medical Sciences","doi-asserted-by":"publisher","award":["791"],"award-info":[{"award-number":["791"]}],"id":[{"id":"10.13039\/501100004160","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s13760-019-01101-x","type":"journal-article","created":{"date-parts":[[2019,2,23]],"date-time":"2019-02-23T16:13:43Z","timestamp":1550938423000},"page":"167-173","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["The efficacy of magnesium oxide and sodium valproate in prevention of migraine headache: a randomized, controlled, double-blind, crossover study"],"prefix":"10.1007","volume":"121","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5912-3732","authenticated-orcid":false,"given":"Narges","family":"Karimi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azadeh","family":"Razian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Heidari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,23]]},"reference":[{"key":"1101_CR1","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/S0025-7125(05)70351-5","volume":"85","author":"VT Martin","year":"2001","unstructured":"Martin VT, Behbehani MM (2001) Towards a rational understanding of migraine trigger factors. Med Clin N Am 85:911\u2013941","journal-title":"Med Clin N Am"},{"key":"1101_CR2","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1046\/j.1468-2982.2003.00546.x","volume":"23","author":"RB Lipton","year":"2003","unstructured":"Lipton RB, Liberman JN, Kolodner KB, igal ME, Dowson A, Stewart WF (2003) Migraine headache disability and health-related quality-of-life: a population-based case-control study from England. Cephalalgia 23:441\u2013450","journal-title":"Cephalalgia"},{"issue":"6 Suppl 4","key":"1101_CR3","first-page":"S17","volume":"44","author":"WF Stewart","year":"1994","unstructured":"Stewart WF, Shechter A, Rasmussen BK (1994) Migraine prevalence. A review of population-based studies. Neurology 44 (6 Suppl 4):S17\u2013S23","journal-title":"Neurology"},{"key":"1101_CR4","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1007\/s10072-012-1200-0","volume":"34","author":"S Shahbeigi","year":"2013","unstructured":"Shahbeigi S, Fereshtehnejad SM, Mohammadi N et al (2013) Epidemiology of headaches in Tehran urban area: a population based cross-sectional study in district 8, year 2010. Neurol Sci 34:1157\u20131166","journal-title":"Neurol Sci"},{"key":"1101_CR5","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1111\/j.1526-4610.2006.00413.x","volume":"46","author":"V Shaygannejad","year":"2006","unstructured":"Shaygannejad V, Janghorbani M, Ghorbani A, Ashtary F, Zakizade N, Nasr V. Comparison of the effect of topiramate and sodium valporate in migraine prevention: a randomized blinded crossover study. Headache 2006;46:642\u2013648","journal-title":"Headache"},{"issue":"2","key":"1101_CR6","first-page":"1","volume":"4","author":"N Karimi","year":"2017","unstructured":"Karimi N, Tavakoli M, Yazdani Charati J, Shamsizade M (2017) Single-dose intravenous sodium valproate (Depakine) versus dexamethasone for the treatment of acute migraine headache: a doubleblind randomized clinical trial. Clin Exp Emerg Med 4 (2):1\u20138","journal-title":"Clin Exp Emerg Med"},{"key":"1101_CR7","first-page":"345","volume":"17","author":"M Rybicka","year":"2012","unstructured":"Rybicka M, Baranowska-Bosiacka I, \u017byluk B, Nowacki P, Chlubek D (2012) The role of magnesium in migraine pathogenesis. Potential use of magnesium compounds in prevention and treatment of migraine headaches. J Elementol 17:345\u2013356","journal-title":"J Elementol"},{"key":"1101_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0022-510X(95)00196-1","volume":"134","author":"KM Welch","year":"1995","unstructured":"Welch KM, Ramadan NM (1995) Mitochondria, magnesium and migraine. J Nneurol Sci 134:9\u201314","journal-title":"J Nneurol Sci"},{"key":"1101_CR9","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1046\/j.1468-2982.1991.1102097.x","volume":"11","author":"J Schoenen","year":"1991","unstructured":"Schoenen J, Sianard -Gainko J, Lenaerts M (1991) Blood magnesium levels in migraine. Cephalalgia 11:97\u201399","journal-title":"Cephalalgia"},{"key":"1101_CR10","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/j.1526-4610.1991.hed3105298.x","volume":"31","author":"F Facchinetti","year":"1991","unstructured":"Facchinetti F, Sances G, Borella P, Genazzani AR, Nappi G (1991) Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium. Headache 31:298\u2013301 24","journal-title":"Headache"},{"key":"1101_CR11","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1161\/01.HYP.8.8.694","volume":"8","author":"M Baudouin-Legros","year":"1986","unstructured":"Baudouin-Legros M, Dard B, Guichency P (1986) Hyperreactivity of platelets from spontaneously hypertensive rats. Role of external magnesium. Hypertension 8:694\u2013699","journal-title":"Hypertension"},{"key":"1101_CR12","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/0304-3940(80)90168-8","volume":"20","author":"BT Altura","year":"1989","unstructured":"Altura BT, Altura BM (1989) Withdrawal of magnesium causes vasospasm while elevated magnesium produced relaxation of tone in cerebral arteries. Neurosci Lett 20:323\u2013327","journal-title":"Neurosci Lett"},{"key":"1101_CR13","first-page":"R734","volume":"263","author":"WB Weglicki","year":"1992","unstructured":"Weglicki WB, Phillips TM (1992) Pathobiology of magnesium deficiency: a cytokine\/neurogenic inflammation hypothesis. Am J Physiol 263:R734\u2013R737","journal-title":"Am J Physiol"},{"key":"1101_CR14","first-page":"2","volume":"21","author":"H Choi","year":"2014","unstructured":"Choi H, Parmar N (2014) The use of intravenous magnesium sulphate for acute migraine: meta-analysis of randomized controlled trials. Eur J Emerg Med 21:2\u20139","journal-title":"Eur J Emerg Med"},{"key":"1101_CR15","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1046\/j.1468-2982.1996.1604257.x","volume":"16","author":"A Peikert","year":"1996","unstructured":"Peikert A, Wilimzig C, K\u00f6hne-Volland F (1996) Prophylaxis of migraine with oral magnesium: results from a prospective, multicenter, placebo-controlled and double-blind randomized study. Cephalalgia 16:257\u2013263","journal-title":"Cephalalgia"},{"key":"1101_CR16","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1046\/j.1468-2982.1996.1606436.x","volume":"16","author":"V Pfaffenrath","year":"1996","unstructured":"Pfaffenrath V, Wessely P, Meyer C, Isler HR, Evers S, Grotemeyer KH, Taner Z, Soycal D, G\u2019bell H, Fischer M (1996) Magnesium in the prophylaxis of migraine\u2014a double-blind, placebo-controlled study. Cephalalgia 16:436\u2013440","journal-title":"Cephalalgia"},{"key":"1101_CR17","first-page":"101","volume":"21","author":"E Koseoglu","year":"2008","unstructured":"Koseoglu E, Talashoglu A, Gonul AS, Kula M (2008) The effects of magnesium prophylaxis in migraine without aura. Magnes Res 21:101\u2013108","journal-title":"Magnes Res"},{"key":"1101_CR18","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1111\/j.1526-4610.2004.04170.x","volume":"44","author":"M Maizels","year":"2004","unstructured":"Maizels M, Blumenfeld A, Burchette R (2004) A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial. Headache 44:885\u2013890","journal-title":"Headache"},{"key":"1101_CR19","first-page":"664","volume":"13","author":"Y Zhou","year":"1998","unstructured":"Zhou Y, Gao L (1998) Flunarizine combined with magnesium polarization liquid on treating refractory migraine. Clin Focus 13:664","journal-title":"Clin Focus"},{"key":"1101_CR20","first-page":"62","volume":"18","author":"CS Hu","year":"2011","unstructured":"Hu CS, Zhou LB (2011) Observation of clinical effects of magnesium valproate combined with venlafaxine HCl in 54 individuals with migraine. China Mod Med 18:62","journal-title":"China Mod Med"},{"key":"1101_CR21","first-page":"6","volume":"11","author":"X Bian","year":"2013","unstructured":"Bian X, Zhu Y, Xia J, Ai HJ, Guo QY, Lu LB, Zhang QW (2013) Clinical observation om potassium magnesium asparate oral soluation combined with flinarizine capsule for migraine prophylaxis. J Comm Med 11:6\u20137","journal-title":"J Comm Med"},{"key":"1101_CR22","first-page":"5","volume":"19","author":"XY Tang","year":"1998","unstructured":"Tang XY, Lin WZ, Zheng XM, Liu CS (1998) Observation of effects of nimodipine and magnesium sulfate combination for treating migraine. J Qiqihar Med Coll 19:5\u20136","journal-title":"J Qiqihar Med Coll"},{"issue":"3","key":"1101_CR23","doi-asserted-by":"publisher","first-page":"174","DOI":"10.14499\/indonesianjpharm27iss3pp174","volume":"27","author":"SM Alghadeer","year":"2016","unstructured":"Alghadeer SM (2016) The efficacy of different oral magnesium supplements for migraine prevention: a literature review. Indones J Pharm 27 (3):174\u2013182","journal-title":"Indones J Pharm"},{"key":"1101_CR24","first-page":"E97","volume":"19","author":"HY Chiu","year":"2016","unstructured":"Chiu HY, Yeh TH, Huang YC, Chen PY (2016) Effects of intravenous and oral magnesium on reducing migraine: a meta-analysis of randomized controlled trials. Pain Physician 19:E97\u2013E112","journal-title":"Pain Physician"},{"key":"1101_CR25","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1017\/S031716710001516X","volume":"39","author":"T Pringsheim","year":"2012","unstructured":"Pringsheim T, Davenport W, Mackie G et al (2012) Canadian Headache Society guideline for migraine prophylaxis. Can J Neurol Sci 39:S1\u2013S59","journal-title":"Can J Neurol Sci"},{"issue":"10","key":"1101_CR26","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1177\/0333102414564891","volume":"35","author":"L Teigen","year":"2015","unstructured":"Teigen L, Boes ChJ (2015) An evidence-based review of oral magnesium supplementation in the preventive treatment of migraine. Cephalalgia 35 (10):912\u2013922","journal-title":"Cephalalgia"},{"key":"1101_CR27","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1046\/j.1468-2982.1992.1202081.x","volume":"12","author":"R Hering","year":"1992","unstructured":"Hering R, Kuritzky A (1992) Sodium valproate in the prophylactic treatment of migraine: a double-blind study versus placebo. Cephalalgia 12:81\u201384","journal-title":"Cephalalgia"},{"issue":"1","key":"1101_CR28","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1177\/0333102411417901","volume":"32","author":"International Headache Society Committee on Clinical Trials in Migraine","year":"2012","unstructured":"International Headache Society Committee on Clinical Trials in Migraine (2012) Guidelines for controlled trials of drugs in migraine. Third edition. A guide for investigators. Cephalalgia 32 (1):6\u201338","journal-title":"Cephalalgia"},{"key":"1101_CR29","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1177\/0333102413485658","volume":"33","author":"Headache Classification Committee of the International Headache Society (IHS)","year":"2013","unstructured":"Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd\u00a0edn (beta version). Cephalalgia 2013; 33:629\u2013808","journal-title":"Cephalalgia"},{"issue":"8","key":"1101_CR30","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1023\/A:1026167214355","volume":"12","author":"MS Bayliss","year":"2003","unstructured":"Bayliss MS, Dewey JE, Dunlap I, Batenhorst AS, Cady R, Diamond ML, Sheftell F (2003 Dec) A study of the feasibility of Internet administration of a computerized health survey: the headache impact test (HIT). Qual Life Res 12 (8):953\u2013961","journal-title":"Qual Life Res"},{"issue":"3","key":"1101_CR31","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1046\/j.1526-4610.2003.03050.x","volume":"43","author":"WF Stewart","year":"2003","unstructured":"Stewart WF, Lipton RB, Kolodner K (2003) Migraine disability assessment (MIDAS) score: relation to headache frequency, pain intensity, and headache symptoms. Headache 43 (3):258\u2013265","journal-title":"Headache"},{"key":"1101_CR32","first-page":"39","volume":"10","author":"A Ghorbani","year":"2011","unstructured":"Ghorbani A, Chitsaz A (2011) Comparison of validity and reliability of the migraine disability assessment (MIDAS) versus headache impact test (HIT) in an Iranian population. Iran J Neurol 10:39\u201342","journal-title":"Iran J Neurol"},{"issue":"6","key":"1101_CR33","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1046\/j.1526-4610.2003.03102.x","volume":"43","author":"F Wang","year":"2003","unstructured":"Wang F, Van Den Eeden SK, Ackerson LM, Salk SE, Reince RH, Elin RJ (2003) Oral magnesium oxide prophylaxis of frequent migrainous headache in children: a randomized, double-blind, placebo-controlled trial. Headache 43 (6):601\u2013610","journal-title":"Headache"},{"issue":"1\u20133","key":"1101_CR34","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s12011-012-9487-5","volume":"150","author":"A Tarighat Esfanjani","year":"2012","unstructured":"Tarighat Esfanjani A, Mahdavi R, Ebrahimi Mameghani M, Talebi M, Nikniaz Z, Safaiyan A (2012) The effects of magnesium, l-carnitine, and concurrent magnesium-l-carnitine supplementation in migraine prophylaxis. Biol Trace Elem Res 150 (1\u20133):42\u201348","journal-title":"Biol Trace Elem Res"},{"issue":"1","key":"1101_CR35","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s10194-015-0516-6","volume":"16","author":"C Gaul","year":"2015","unstructured":"Gaul C, Diener H-C, Danesch U (2015) Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial. J Headache Pain 16 (1):32","journal-title":"J Headache Pain"},{"issue":"2000","key":"1101_CR36","first-page":"179","volume":"1","author":"S Demirkaya","year":"2001","unstructured":"Demirkaya S, Dora B, Topcuoglu MA, Vural O, U HU (2001) A comparative study of magnesium, flunarizine and amitriptyline in the prophylaxis of migraine. J Headache Pain 1 (2000):179\u2013186","journal-title":"J Headache Pain"},{"key":"1101_CR37","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1046\/j.1526-4610.2002.02075.x","volume":"42","author":"A Mauskop","year":"2002","unstructured":"Mauskop A, Altura BT, Altura BM (2002) Serum ionized magnesium levels and serum ionized calcium\/ionized magnesium ratios in women with menstrual migraine. Headache 42:242\u2013248","journal-title":"Headache"},{"issue":"11","key":"1101_CR38","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1093\/ajcn\/34.11.2364","volume":"34","author":"GE Abraham","year":"1981","unstructured":"Abraham GE, Lubran MM (1981) Serum and red cell magnesium levels in patients with premenstrual tension. Am J Clin Nutr 34 (11):2364\u20132366","journal-title":"Am J Clin Nutr"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13760-019-01101-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-019-01101-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-019-01101-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T15:04:06Z","timestamp":1615129446000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13760-019-01101-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,23]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["1101"],"URL":"https:\/\/doi.org\/10.1007\/s13760-019-01101-x","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,23]]},"assertion":[{"value":"4 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}